Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver DiseaseSummary
Background & Aims: Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are emerging as leading causes of liver disease worldwide. Currently, no specific pharmacologic therapy is available for NAFLD/NASH, which has been recognized as one of the major unmet medical nee...
Main Authors: | Emmelie Cansby, Esther Nuñez-Durán, Elin Magnusson, Manoj Amrutkar, Sheri L. Booten, Nagaraj M. Kulkarni, L. Thomas Svensson, Jan Borén, Hanns-Ulrich Marschall, Mariam Aghajan, Margit Mahlapuu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Cellular and Molecular Gastroenterology and Hepatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352345X18301796 |
Similar Items
-
Depletion of protein kinase STK25 ameliorates renal lipotoxicity and protects against diabetic kidney disease
by: Emmelie Cansby, et al.
Published: (2020-12-01) -
Lipid droplet-associated kinase STK25 regulates peroxisomal activity and metabolic stress response in steatotic liver[S]
by: Annika Nerstedt, et al.
Published: (2020-02-01) -
Silencing of STE20-type kinase STK25 in human aortic endothelial and smooth muscle cells is atheroprotective
by: Emmelie Cansby, et al.
Published: (2022-04-01) -
STE20‐Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes
by: Mara Caputo, et al.
Published: (2021-07-01) -
GCKIII kinases in lipotoxicity: Roles in NAFLD and beyond
by: Margit Mahlapuu, et al.
Published: (2022-10-01)